BioNTech

v1.0.1

Provides detailed insights into BioNTech's mRNA technology, vaccine development, cancer immunotherapy, and its global pharmaceutical impact.

⭐ 0· 102·1 current·1 all-time

by@hanxueyuan

OpenClaw Prompt Flow

Install with OpenClaw

Best for remote or guided setup. Copy the exact prompt, then paste it into OpenClaw for hanxueyuan/biontech.

Previewing Install & Setup.

Prompt PreviewInstall & Setup

Install the skill "BioNTech" (hanxueyuan/biontech) from ClawHub.
Skill page: https://clawhub.ai/hanxueyuan/biontech
Keep the work scoped to this skill only.
After install, inspect the skill metadata and help me finish setup.
Use only the metadata you can verify from ClawHub; do not invent missing requirements.
Ask before making any broader environment changes.

Command Line

CLI Commands

Use the direct CLI path if you want to install manually and keep every step visible.

OpenClaw CLI

Bare skill slug

openclaw skills install biontech

ClawHub CLI

Package manager switcher

npx clawhub@latest install biontech

Security Scan

VirusTotal

Benign

View report →

OpenClaw

Benign

high confidence

✓

Purpose & Capability

Name and description promise educational content about BioNTech; the skill is instruction-only, requests no binaries or credentials, and contains only topical text — the requested capabilities match the stated purpose.

✓

Instruction Scope

SKILL.md contains static, topical instructions and a 'read_when' trigger list. It does not ask the agent to read files, access environment variables, run shell commands, or transmit data to third parties. No scope creep detected.

✓

Install Mechanism

No install spec and no code files. Because nothing is written to disk or downloaded, there is minimal install risk.

✓

Credentials

The skill declares no required env vars, credentials, or config paths. There is nothing disproportionate or unexplained.

✓

Persistence & Privilege

always is false and model invocation is normal (not disabled). The skill does not request persistent system presence or modify other skills.

Assessment

This skill is informational and contains only static content in SKILL.md, so it does not request credentials or install software. Before installing, consider that: (1) the content may be out of date or contain minor factual errors (I noted a small metadata/version mismatch between registry version 1.0.1 and SKILL.md version 1.0.0 and some timeline items may be imprecise), (2) as with any third-party skill, review the publisher/trustworthiness (source is 'unknown'), and (3) if you need authoritative or up-to-date scientific/financial data, cross-check with primary sources (company filings, peer-reviewed papers, or official press releases). Otherwise there are no technical red flags preventing installation.

Like a lobster shell, security has layers — review code before you run it.

latestvk97ehf2p555q7tfjs1k3q697sh85cfxz

102downloads

0stars

2versions

Updated 4d ago

v1.0.1

MIT-0

BioNTech — mRNA 革命的核心

历史时间线

2008: Ugur Sahin 和 Özlem Türeci 夫妇在美因茨创立 BioNTech
2010s: 专注 mRNA 癌症免疫疗法研发
2018: 在纳斯达克上市
2020: 与辉瑞合作开发新冠疫苗 BNT162b2
2020.11: 疫苗有效性 95%——震惊全球
2021: 新冠疫苗全球交付超 30 亿剂
2023: 转型癌症 mRNA 疗法
2024: 个体化癌症疫苗进入 III 期临床

商业模式

mRNA 疗法平台 + 疫苗 + 肿瘤免疫。新冠疫苗带来了约 $400 亿收入。核心能力是将 mRNA 技术应用于多种疾病。

护城河分析

mRNA 技术平台的广泛适用性——从疫苗到肿瘤免疫到蛋白质替代疗法。与辉瑞的全球分销网络合作。Sahin-Türeci 夫妇的学术领导力和 20+ 年 mRNA 研究积累。

关键数据

新冠疫苗累计营收约 $400 亿
市值约 €300 亿（2023）
员工约 5000 人
癌症 mRNA 疗法管线超 20 个项目

有趣事实

BioNTech 的创始人 Ugur Sahin 和 Özlem Türeci 是夫妻——Sahin 是 CEO，Türeci 是首席医疗官。他们在土耳其长大，后来在德国相遇并结婚。他们的公司名字 "BioNTech" 来自 "Bio"（生物学）+ "N"（他们姓氏的首字母）+ "Tech"（技术）。

Comments

Loading comments...